The LIAISON® HBc IgM assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of IgM immunoglobulin to hepatitis B core antigen (IgM anti-HBc) in human serum or plasma samples.

The test has to be performed on the LIAISON® Analyzer family.

Number of tests: 50/kit